Enzon Pharmaceuticals, Inc. (ENZND)
4.03
-1.85
(-31.46%)
USD |
OTCM |
Mar 25, 16:00
Enzon Pharmaceuticals Free Cash Flow : -3.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -77.20M |
| Curis, Inc. | -27.20M |
| Windtree Therapeutics, Inc. | -15.12M |
| Halozyme Therapeutics, Inc. | 644.59M |
| AIM ImmunoTech, Inc. | -13.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.682M |
| Free Cash Flow Per Share (Quarterly) | -0.919 |
| Free Cash Flow to Equity (Quarterly) | -0.682M |
| Free Cash Flow to Firm (Quarterly) | -0.682M |
| Free Cash Flow Yield | -3.91% |